MeVis Medical Solutions AG Logo

MeVis Medical Solutions AG

ISIN

DE000A0LBFE4

Ticker

M3V

Sector

Health Care

Sub-Industry

Health Care Technology

Country

Germany

Year Founded

1998

About MeVis Medical Solutions AG

Company Description

MeVis Medical Solutions was founded in 1997 and is one of the world's leading independent developers and providers of software products for image-based medicine, particularly digital radiology.

The importance and complexity of medical data acquired from today's imaging modalities like computer tomography, magnetic resonance tomography, ultrasound and mammography is growing steadily. MeVis products analyze and process this data to provide medical professionals crucial information for early diagnosis and therapy in the areas of cancer, particularly breast cancer, neurological disorders and lung conditions.

The company develops its software solutions in close cooperation with world's leading clinical experts and has established longstanding industry partnerships with original equipment manufacturers (OEMs) of imaging devices and sells its products primarily through these channels.

Headcount

94

Served Area

Worldwide

Headquarters

Caroline-Herschel-Straße 1
28359, Bremen
Germany

Filings & Publications

  • Consolidated Report 2022 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2022 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2017 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2017 - Q2 English πŸ‡¬πŸ‡§

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.